Healthcare Equity
Invesco Global Health Care Innovation
Last updated: 2026-03-13
The Verdict
Invesco Global Health Care Innovation charges an expense ratio of 1.93%. On a $100,000 portfolio, that's $1,930 per year in fees. Supreme.PM's decoded model provides similar exposure at a fraction of the cost, potentially saving $1,680 per year.
Expense Ratio
1.93%
Star Rating
2/ 5
Market Beta
1.02
Supreme.PM Cost
0.25%
Annual platform fee
Fee Analysis
Invesco Global Health Care Innovation charges 1.93% annually. Supreme.PM offers equivalent exposure for 0.25%, a savings of 1.68 percentage points.
Data sources: Refinitiv Lipper, SEC EDGAR Filings, Supreme.PM Analytics
Past performance does not guarantee future results. Model returns are backtested and may not reflect actual trading conditions.
Related
Healthcare Equity Category
Browse all Healthcare Equity funds
Healthcare Equity Rankings
Top-rated Healthcare Equity funds
Our Methodology
How we decode fund strategies
AXA Framlington Health
2-star rated
Pictet-Health
1-star rated
Wellington Global Health Care Equity
2-star rated
Polar Capital Healthcare Opportunities
4-star rated
Goldman Sachs Glo Fut Hlth Care Eq Ptfl Base
2-star rated
Frequently Asked Questions
What is the expense ratio of Invesco Global Health Care Innovation?
Invesco Global Health Care Innovation has an expense ratio of 1.93%. Supreme.PM's decoded model provides similar exposure at a significantly lower cost.
How does Supreme.PM replicate Invesco Global Health Care Innovation?
Supreme.PM uses AI to analyze the fund's holdings and trading patterns, creating a decoded model that tracks the fund's performance.
What are the risks of fund replication?
While our models aim for high correlation, they may not perfectly match the fund's returns due to timing differences in rebalancing, transaction costs, and disclosure delays. Backtested results may not reflect future performance.
Get This Strategy
Start investing with Supreme.PM's decoded model and save on fees while capturing similar returns.